|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07C 217/74 | |
| A61K 31/138 | |||
| A61P 3/00 | |||
| A61P 25/00 |
| (11) | Patento numeris | 2531485 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11740324.6 |
| Europos patento paraiškos padavimo data | 2011-02-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-12-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-04-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/023535 |
| Data | 2011-02-03 |
| (87) | Numeris | WO 2011/097336 |
| Data | 2011-08-11 |
| (30) | Numeris | Data | Šalis |
| 301441 P | 2010-02-04 | US |
| (72) |
KOZIKOWSKI, Alan, US
ROTH, Bryan, US
SVENNEBRING, Andreas, US
CHEN, Gang, US
CHO, Sung, Jin, KR
|
| (73) |
The Board of Trustees of the University of Illinois,
352 Henry Administration Building 506 South Wright Street, Urbana, IL 61801,
US
The University of North Carolina at Chapel Hill, 222 East Cameron Avenue 308 Bynum Hall Campus Box 4105, Chapel Hill, NC 27599-4105, US |
| (54) | HIGHLY SELECTIVE 5-HT(2C) RECEPTOR AGONISTS HAVING ANTAGONIST ACTIVITY AT THE 5-HT(2B) RECEPTOR |
| HIGHLY SELECTIVE 5-HT(2C) RECEPTOR AGONISTS HAVING ANTAGONIST ACTIVITY AT THE 5-HT(2B) RECEPTOR |